{"url":"https://www.moneycontrol.com/news/business/glenmark-gets-usfda-nod-for-generic-ophthalmic-solution-12724744.html","title":"Glenmark gets USFDA nod for generic ophthalmic solution","description":"The final approval by the US Food \u0026 Drug Administration (USFDA) is for brimonidine tartrate and timolol maleate ophthalmic solution of strength 0.2 per cent/0.5 per cent, Glenmark said in a statement.Glenmark gets USFDA nod for generic ophthalmic solution","content":"Glenmark Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic brimonidine tartrate and timolol maleate ophthalmic solution indicated in the treatment increased pressure in the eye caused by glaucoma or other conditions. The final approval by the US Food \u0026 Drug Administration (USFDA) is for brimonidine tartrate and timolol maleate ophthalmic solution of strength 0.2 per cent/0.5 per cent, Glenmark said in a statement. The company's brimonidine tartrate and timolol maleate ophthalmic solution, 0.2 per cent/0.5 per cent has been determined by the USFDA to be bioequivalent and therapeutically equivalent to Combigan ophthalmic solution, 0.2 per cent/0.5 per cent of AbbVie, Inc, it added. Combigan ophthalmic solution, 0.2 per cent/0.5 per cent achieved annual sales of approximately USD 290 million, the company said citing IQVIATM sales data for the 12-month period ended March 2024. ","cleaned_content":"glenmark pharmaceuticals ltd on friday said it has received final approval from the us health regulator for its generic brimonidine tartrate and timolol maleate ophthalmic solution indicated in the treatment increased pressure in the eye caused by glaucoma or other conditions the final approval by the us food drug administration usfda is for brimonidine tartrate and timolol maleate ophthalmic solution of strength \u003cZERO_PERCENT\u003e \u003cZERO_PERCENT\u003e glenmark said in a statement the companys brimonidine tartrate and timolol maleate ophthalmic solution \u003cZERO_PERCENT\u003e \u003cZERO_PERCENT\u003e has been determined by the usfda to be bioequivalent and therapeutically equivalent to combigan ophthalmic solution \u003cZERO_PERCENT\u003e \u003cZERO_PERCENT\u003e of abbvie inc it added combigan ophthalmic solution \u003cZERO_PERCENT\u003e \u003cZERO_PERCENT\u003e achieved annual sales of approximately usd \u003cTWO_HUNDRED\u003e million the company said citing iqviatm sales data for the \u003cONE_TEN\u003e month period ended march \u003cTWO_THOUSAND\u003e","timestamp":"2024-05-17T10:34:00+05:30","market_timestamp":"2024-05-17T10:34:00+05:30","off_market_hours":false}